Search Results 1131-1140 of 18067 for multiple%20sclerosis
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis. Cogn Behav Neurol. 2014 Mar ...
... multiple myeloma. This study will also assess the ... Diagnosis of multiple ... Daratumumab monotherapy will be limited to approximately 20 percent of the total ...
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).
Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunosuppressive therapy, such as dexamethasone, may ...
rehabilitation, Parkinson's disease, Concussion, Brain cancer, Brain tumor, Multiple sclerosis, Muscular dystrophy, Balance problem, Dystonia, Movement ...
The purpose of this study is to investigate 2 dose regimens in pediatric subjects 2 to < 17 years of age with confirmed or possible Chronic Inflammatory ...
https://www.merckmanuals.com/professional/neurologic-disorders/seizure-disorders/seizure-disorders?query=frontal%20lobe%20seizure#. Accessed May 5, 2023 ...
Multiple sclerosis or; Optic neuritis (eye problem) ... A maintenance dose of 20 mg is given at week 4 and every other week thereafter. ... Children 2 to 17 years of ...
Judy Phillips found hope when hope was running out thanks to a physician willing to try new (and old) treatments, a team of "wonderful nurses," and the ...
May 20, 2014. Cancer. Mayo Clinic First to Show Virotherapy is Promising Against Multiple Myeloma (pkg). Robert Nellis. May 16, 2014. Minnesota. Mayo Study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.